$0.120
-0.140 (-53.96%)
At Close: Jun 03, 2026
Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth
06:15am, Wednesday, 03'rd Jun 2026
WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discov
Inotiv Provides Notice Regarding Cybersecurity Incident
04:30pm, Friday, 13'th Feb 2026
WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analy
Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript
01:44pm, Monday, 09'th Feb 2026
Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript
Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
07:00am, Monday, 09'th Feb 2026
WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discov
Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026
06:30am, Wednesday, 04'th Feb 2026
WEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analy
Ernexa Therapeutics (NASDAQ:ERNA) vs. Inotiv (NASDAQ:NOTV) Critical Review
02:16am, Thursday, 15'th Jan 2026
Inotiv (NASDAQ: NOTV - Get Free Report) and Ernexa Therapeutics (NASDAQ: ERNA - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
09:15am, Tuesday, 13'th Jan 2026
WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analy
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
09:00am, Thursday, 11'th Dec 2025
WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and
Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript
02:03am, Thursday, 04'th Dec 2025
Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
04:05pm, Wednesday, 03'rd Dec 2025
– Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million– Fiscal 2025 revenue increased 4.5% to $513.0 million– Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 mill
Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
07:00am, Tuesday, 25'th Nov 2025
Building a Unified, Client-Focused, Early Stage CRO Through Strategic Expansion and Service Development Powers 448% Revenue Growth from Fiscal Year 2021 to Fiscal Year 2024 Building a Unified, Client-
WEST LAFAYETTE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analy
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results
04:05pm, Monday, 17'th Nov 2025
Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 Million
Halper Sadeh LLC Encourages Inotiv, Inc. Shareholders to Contact the Firm to Discuss Their Rights
10:20am, Friday, 24'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Inotiv, Inc. (NASDAQ: NOTV) breached their fiduciary duties to shar
Inotiv, Inc. to Participate in Three Investor Conferences in September 2025
07:00am, Wednesday, 13'th Aug 2025
WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analy
Sign In
Buy NOTV